Plaquenil
Plaquenil

0.53
Regulates overactive immune responses and dampens systemic autoimmune inflammation for Autoimmune Support and Antiparasitics by interfering with lysosomal function in macrophages to limit antigen presentation.


Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Hydroxychloroquine
Reference Brand
Hydroxychloroquine
Product Origin
Generic Alternative
Reference Manufacturer
Sanofi
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Antiparasitics, Autoimmune Support
Product Category
Antimalarial, Antirheumatic
Pharmacological Class
Aminoquinoline
Clinical Indications
Malaria, Lupus, Rheumatoid arthritis
Manufacturer Description
Indicated to help manage autoimmune flare-ups and provides prevention against specified parasitic infections.
Mechanism of Action
Interferes with the communication of the immune system and manages parasitic survival within cells, assisting in the moderation of abnormal inflammatory responses.
Route of Administration
Oral
Onset Time
Several weeks
Duration
Long half-life
Contraindications
Retinal damage
Severe Adverse Events
Vision changes, Cardiac toxicity
Common Side Effects
Nausea
Uncommon Side Effects
Abdominal cramps, Skin rash
Drug Interactions
Digoxin
Pregnancy Safety Warnings
Use with caution.
Age Restrictions
Monitor in elderly.
Storage Guidelines
Store at room temperature.
Related Products
Chloroquine, Methotrexate

Plaquenil FAQ

How do digital health platforms facilitate evaluation and access to Plaquenil in Singapore?

Digital platforms provide a secure infrastructure for users to link with healthcare professionals, facilitating the necessary clinical verification and evaluation required for accessing Plaquenil.

Why are there cost variations between multi-source generic Hydroxychloroquine formulations and originator brands?

Formulation economics, including research investment, manufacturing standards, and supply chain logistics, contribute to the variance in cost observed between originator brands and multi-source generic products.

How can patients in Singapore verify the regulatory compliance and sourcing standards of digital health directories?

Verification of compliance involves reviewing the platform's alignment with Health Sciences Authority standards and ensuring that the service maintains transparent protocols for documentation and medical oversight.

What are the logistical or regulatory considerations when utilizing cross-border facilitation for Plaquenil?

Importing medications requires adherence to stringent national regulations, often necessitating specific documentation to clear local customs protocols and ensuring the medication remains consistent with domestic quality standards.

How does the clinical bioequivalence of Plaquenil compare to other generic Hydroxychloroquine alternatives?

Plaquenil represents the originator brand, and generic analogs are engineered to demonstrate clinical bioequivalence, meaning they deliver the same quantity of the active ingredient to the bloodstream at comparable rates.

What is Hydroxychloroquine?

Hydroxychloroquine functions as a synthetic 4-aminoquinoline compound utilized primarily for modulating immune system activity. Practitioners often include this agent in protocols designed for managing chronic autoimmune conditions. Biological stability and long-term activity profiles define its role in sustained care strategies.

Clinical utility centers on its ability to alter cellular signaling and adjust inflammatory responses within the body. Diverse patient populations rely on this compound to maintain symptom control over extended duration periods. Medical experts facilitate its integration into care plans following thorough diagnostic assessment.

Regulatory & Classification Profile

Regulatory status for Hydroxychloroquine within Singapore classifies the compound as a Prescription-Only Medicine (POM). Governance by the Health Sciences Authority (HSA) ensures that distribution and access remain within strict healthcare oversight frameworks. Individuals seeking this therapy must secure an evaluation from a medical professional within the local jurisdiction to ensure compliance with national standards.

Formulations & Associated Medications

Plaquenil acts as the originator brand formulation containing the active ingredient Hydroxychloroquine. Digital health directories facilitate access to this medication, ensuring patients have a pathway to obtain necessary supplies. Available formulations accessible through our website include Plaquenil pill in strengths of 200mg and 400mg.

Therapeutic Applications

Long-term management of systemic lupus erythematosus requires consistent adherence to established protocols. Rheumatoid arthritis symptom moderation represents another primary application for this compound. Management of malaria prophylaxis constitutes an additional key use case within tropical medical settings. Patients suffering from discoid lupus also find support through the regulatory adjustment provided by this agent.

Biological Action

Hydroxychloroquine performs its function by concentrating in acidic cell compartments. Once inside these areas, the compound increases the local acidity levels, which impairs the function of specific intracellular structures. Such mechanisms assist in disrupting the activation of immune pathways responsible for inflammatory symptoms. Effectiveness develops gradually, often requiring weeks of consistent intake before observable changes occur in the patient.

Treatment Landscape & Drug Class

Hydroxychloroquine belongs to the aminoquinoline chemical family, a group of agents historically significant in medical science. Modern protocols utilize this class primarily for its success in suppressing immune-mediated inflammation. Therapeutic strategies involving these compounds focus on long-term disease modification rather than immediate relief, emphasizing the necessity of ongoing monitoring by medical professionals.

Understanding the Safety Profile

Physiological systems including the visual, hepatic, and central nervous systems experience interactions with Hydroxychloroquine throughout the duration of therapy. Careful observation of baseline health metrics remains a prerequisite before initiation of any regimen. Chronic use necessitates intermittent screening to monitor systemic responses and tissue health. Refer to the clinical data tables provided for specific contraindications, interactions, and potential reactions.

Clinical Disclosure

Hydroxychloroquine serves as a specialized agent for managing autoimmune and parasitic conditions. Medicines like Plaquenil differ in strength based on formulation, ranging across established dose tiers. We do not provide medical advice, diagnosis, or treatment determinations. Always review the included clinical labeling and consult with a healthcare professional to determine if this therapy suits your specific health profile and to ensure proper clinical oversight throughout the course of your care.

Clinical Glossary

Autoimmune
Biological state where the immune system directs activity against the healthy tissue of the host.
Bioequivalence
Measured performance similarity between a generic formulation and an originator brand.
Prophylaxis
Medical action taken to support the prevention of disease or infection before exposure occurs.
Systemic
Affecting the entire body rather than being limited to a localized area or symptom site.
Information associated with Plaquenil is curated and periodically reviewed using established medical references and prescribing guidelines. Content is intended for general awareness and should be verified with a licensed healthcare professional before use.
Categories